BioFire Diagnostics provides syndromic infectious disease diagnostics, focusing on rapid and accurate molecular testing.

BioFire Diagnostics

With more than 25 years of molecular experience, BioFire Diagnostics, LLC (now bioMérieux) sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire® FilmArray® System.

The FDA-cleared BioFire System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. Whether you’re trying to determine optimal therapy for a septic patient or pinpoint which respiratory pathogen is making a young child sick, the BioFire System can provide definitive answers—fast.

BioFire Diagnostics, LLC

The BioFire brand is evolving and there are some changes we’re excited to show you. bioMérieux, a global presence and world leader in infectious disease diagnostics, acquired BioFire in 2014 and it’s time to align our two companies. In January 2022, the BioFire product line will be folded into the bioMérieux product portfolio. As a company, it will simply be called bioMérieux. Read our newest blog post to see what the future holds for this amazing company. #WeArebioMerieux #NewBeginnings https://bit.ly/3o01mfV

Myriad Genetics is a molecular diagnostics company specializing in personalized medicine and cancer genetics.

Myriad

LinkedIn is a professional networking platform that offers various services including job searching, professional networking, and career development.

LinkedIn

Chromatin is a biotechnology company focused on developing and commercializing technologies for crop improvement and sustainable agriculture.

Chromatin

Cepheid is a leading molecular diagnostics company that develops, manufactures, and markets accurate and easy-to-use molecular systems.

Cepheid

Abaxis Inc is a global diagnostics company that develops, manufactures, and markets portable blood analysis systems for use in any veterinary or human patient-care setting.

Abaxis Inc

bioMérieux is a global leader in microbiology and infectious disease diagnostics, providing comprehensive diagnostic solutions to improve patient health and ensure consumer safety. The company has integrated the BioFire product line into its portfolio, offering a wider range of solutions and technologies to address pressing healthcare issues.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Oct 2, 2024 10:44 AM	4bda7372
public peers	general	Oct 2, 2024 10:44 AM	4cfeea88
news daily refresh	general	Oct 2, 2024 10:44 AM	77b2c821
news processing daily refresh	general	Oct 2, 2024 10:44 AM	f3261ce1
news impact assignment daily	general	Oct 2, 2024 10:44 AM	3112629e
news processing basic	general	Oct 2, 2024 10:44 AM	a7ffd08a
company summary	general	Oct 2, 2024 10:44 AM	00dcaff5
signals	general	Oct 2, 2024 10:44 AM	7b37e301
crunchbase trigger	general
crunchbase profile	general
li profile	general	Oct 2, 2024 10:44 AM	2d2b5853
translate crunchbase fundingrounds	general
peers	general	Oct 2, 2024 10:44 AM	f4ebd3a9
news basic	general	Oct 2, 2024 10:44 AM	a649f866
bundesanzeiger	filings	Oct 2, 2024 10:44 AM	3d1dfc20
merger acquisitions	company_analysis	Oct 2, 2024 10:44 AM	2db6f0b9
financials download nd	financials
private financials	financials

COM:BIOFIREDX

BioFire Diagnostics